Delivery Order SPE2DB20D1100-SPE2DB25FA2N7
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $37,962.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting, to support DLA's medical supply requirements. The contract has an ultimate completion date of November 29, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was...
This federal contract award, valued at $5,550.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 2, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $7,116.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron Orally Disintegrating Tablets (ODT) 4 mg, a medication used to treat nausea and vomiting, with a completion date of December 17, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open...
This federal contract award is a delivery order valued at $14,243.04 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,727.71 delivery order contract is for the supply of Ondansetron ODT 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a period of performance through July 26, 2024 and utilizes a firm fixed-price pricing type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $9,466.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has an ultimate completion date of September 25,...
This federal contract award, valued at $1,871.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of November 22, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $34,995.06 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,746.04 firm fixed-price delivery order is for Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $93,280.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ondansetron oral disintegrating tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside....